RAIMONDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.835
EU - Europa 472
AS - Asia 314
SA - Sud America 12
AF - Africa 11
OC - Oceania 2
Totale 2.646
Nazione #
US - Stati Uniti d'America 1.819
IT - Italia 161
SG - Singapore 127
IN - India 97
DE - Germania 87
SE - Svezia 70
CN - Cina 66
FI - Finlandia 56
GB - Regno Unito 20
UA - Ucraina 19
BG - Bulgaria 14
CA - Canada 14
RU - Federazione Russa 13
TG - Togo 10
AR - Argentina 9
IE - Irlanda 9
ID - Indonesia 8
RO - Romania 6
CH - Svizzera 5
BR - Brasile 3
FR - Francia 3
JP - Giappone 3
LT - Lituania 3
BE - Belgio 2
HK - Hong Kong 2
IL - Israele 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
EE - Estonia 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MY - Malesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.646
Città #
Fairfield 297
Chandler 190
Ashburn 155
Seattle 132
Houston 116
Woodbridge 112
Singapore 94
Cambridge 93
Wilmington 83
Rome 65
Princeton 52
Ann Arbor 48
Plano 43
Dearborn 41
Grafing 41
Lawrence 35
San Paolo di Civitate 34
Santa Clara 32
Beijing 31
Boston 27
Des Moines 24
Helsinki 22
Millbury 19
San Diego 19
Fremont 15
New York 14
Sofia 14
Toronto 12
Andover 11
Lomé 10
Dublin 9
Bremen 8
Federal 8
Jakarta 8
Moscow 8
Munich 7
Kunming 6
Nanjing 6
Phoenix 6
Hefei 5
London 5
Bern 4
Bühl 4
Falkenstein 4
Falls Church 4
Liverpool 4
Norwalk 4
Guangzhou 3
Priverno 3
Redmond 3
Zhengzhou 3
Arezzo 2
Ariccia 2
Boardman 2
Brussels 2
Florence 2
Foggia 2
Gunzenhausen 2
Hong Kong 2
Islington 2
Jacksonville 2
Kilburn 2
Latina 2
Los Angeles 2
Mannheim 2
Milan 2
Naples 2
Southend 2
São Paulo 2
Almaty 1
Auckland 1
Bangalore 1
Bari 1
Basking Ridge 1
Bratislava 1
Brooklyn 1
Buffalo 1
Canuelas 1
Chicago 1
Colombo 1
Coventry 1
Dalmine 1
Denver 1
Dubai 1
Edinburgh 1
Frankfurt 1
Frankfurt am Main 1
Gangdong-gu 1
Genova 1
Gothenburg 1
Groningen 1
Haifa 1
Hangzhou 1
Hanoi 1
Harbin 1
Jinhua 1
Laurel 1
Leawood 1
Manila 1
Muizenberg 1
Totale 2.060
Nome #
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 113
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer 105
Circulating tumor cells identify patients with super-high-risk non-muscle-invasive bladder cancer: updated outcome analysis of a prospective single-center trial 101
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma 97
Circulating tumor cells in right-and left-sided colorectal cancer 95
EpCAM expressing circulating tumor cells in colorectal cancer 91
Circulating tumor cells count and characterization in a male breast cancer patient 85
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. 85
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: a molecular shield to evade immune system? 80
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells 80
The role of capecitabine in the management of breast cancer in elderly patients 78
EGFR inhibitor as second-line therapy in a patient with mutant RAS metastatic colorectal cancer: circulating tumor DNA to personalize treatment 78
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 77
Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. 77
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 76
Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. 73
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 72
Comment on: isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties 70
Circulating tumor cells in high-risk nonmetastatic colorectal cancer 69
Circulating Tumor Cells in Cancer Therapy: Are we off Target? 67
Circulating tumor cells: Exploring intratumor heterogeneity of colorectal cancer 66
Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II) 65
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 64
Neoadjuvant targeted therapy in renal cell carcinoma 59
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 56
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 54
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 52
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. 51
The End of Chemotherapy in Renal Cell Carcinoma: For Much But Not for All 50
Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 50
How circulating tumor cells escape from multidrug resistance: translating molecular mechanisms in metastatic breast cancer treatment. 50
Controversies in circulating tumor cell count during therapy 48
Circulating tumor cells: highlight on practical implications. 43
Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo. 41
Circulating tumor cells in early bladder cancer: insight into micrometastatic disease 41
Anaemia and erythropoietic growth factors supportive treatments in colorectal cancer 39
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma. 39
Start-therapy in cancer pain management: news from the past 39
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. 38
Circulating tumor cells isolation: The “post-EpCAM era” 37
Anemia As A Predictive Factor In Colorectal Cancer (CRC) Patients (PTS) 35
Circulating tumor cells in young and elderly patients with colorectal cancer: "lupus et agnus". 22
BIS ETORICOXIB AND ANASTROZOL: NEW FRONTIERS IN. BREAST CANCER TARGET THERAPY? 19
null 19
null 17
Hpv and cancer. Is this all Eve's fault? 16
Totale 2.779
Categoria #
all - tutte 8.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020414 0 0 0 0 0 95 88 64 65 58 32 12
2020/2021237 22 18 18 13 7 14 2 5 23 100 14 1
2021/2022463 3 21 46 11 60 8 16 52 26 40 88 92
2022/2023557 96 118 31 63 68 74 12 26 43 3 21 2
2023/2024247 13 34 7 26 23 40 3 26 1 42 20 12
2024/2025210 12 30 46 33 42 47 0 0 0 0 0 0
Totale 2.779